UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$941,000
-56.7%
384,000
-54.9%
0.00%
-50.0%
Q4 2014$2,173,000
-44.9%
852,100
+54.3%
0.00%
-50.0%
Q3 2014$3,942,000
-33.2%
552,100
-39.0%
0.00%
-33.3%
Q2 2014$5,901,000
+12.1%
905,100
+13.7%
0.01%0.0%
Q1 2014$5,263,000
+83.8%
796,200
+31.8%
0.01%
+100.0%
Q4 2013$2,864,000
-4.4%
604,3000.0%0.00%
-25.0%
Q3 2013$2,997,000
-4.8%
604,3000.0%0.00%0.0%
Q2 2013$3,148,000604,3000.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 1,320,000$9,425,00010.46%
RA Capital Management 4,869,261$34,767,0004.11%
GREAT POINT PARTNERS LLC 400,000$2,856,0001.23%
Healthcare Value Capital, LLC 100,000$714,0000.69%
DSC Advisors, L.P. 175,000$1,250,0000.63%
Quantitative Systematic Strategies LLC 107,416$803,0000.47%
Visium Asset Management, LP 4,093,890$29,230,0000.43%
Rhenman & Partners Asset Management AB 201,171$1,436,0000.42%
EAM Investors, LLC 277,807$1,984,0000.40%
ESSEX INVESTMENT MANAGEMENT CO LLC 354,861$2,534,0000.39%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders